RFK Jr.'s Future With Trump; 'Metabolic Psychiatry' Appointee; Kratom Ban Backtrack

Who is covering this

1. Chron Center Factuality: Mostly factual US 20 hours ago
   RFK Jr. eases access to unproven peptides despite opposition from FDA scientists

   Food and Drug Administration staffers had little input on the Trump administration's decision that eases access to peptide drugs favored by Health Secretary Robert F. Kennedy Jr. That’s according to people familiar with the policy’s development who were interviewed by The...

2. Medpagetoday Center Factuality: Mostly factual US 23 hours ago
   RFK Jr. Eases Access to Unproven Peptides Despite Opposition From FDA Scientists

   (MedPage Today) -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., and FDA scientific staffers had little input on the decision and opposed the changes, according...

3. Medpagetoday Center Factuality: Mostly factual US 1 day ago
   RFK Jr.'s Future With Trump; 'Metabolic Psychiatry' Appointee; Kratom Ban Backtrack

   (MedPage Today) -- There are "zero" signs that HHS Secretary Robert F. Kennedy Jr. will leave the Trump administration after the midterms. (Axios) Kennedy is reportedly considering Shebani Sethi, MD, a psychiatrist who coined the term "metabolic...